🇺🇸 FDA

Company profile · Sponsor

Huahui

Huahui Health

C55607B · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Huahui (C55607B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C55607B
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. HH-003(20mg/kg)

    Huahui

    Chronic Hepatitis Delta Virus Infection

    phase 2 mab completed

    1 trial

  2. Will receive HH-009 injection 20 mg/kg, Q3W

    Huahui

    Advanced or Unresectable Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Huahui?

Huahui (C55607B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Huahui sponsor?

We track 2 ClinicalTrials.gov-linked programs for Huahui, including HH-003(20mg/kg) and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Huahui company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.